| 期 |
栏目 |
标题 |
文件 |
| 卷 78, 编号 5 (2003) |
Editorial |
Use of monoclonal antibodies to tumor necrosis factor (the drug remicade) in rheumatoid arthritis: pilot results |
|
| 卷 78, 编号 5 (2003) |
Editorial |
Synovial membrane in early rheumatoid arthritis: clinicomorphological comparisons |
|
| 卷 79, 编号 12 (2004) |
Editorial |
Antibodies to cyclic citrullinized peptide in rheumatoid arthritis |
|
| 卷 80, 编号 5 (2008) |
Editorial |
Early diagnosis of rheumatoid arthritis in modern clinical practice (results of a follow-up of a Moscow cohort of early arthritis patients participating in the program RADICAL) |
|
| 卷 84, 编号 8 (2012) |
Editorial |
The efficiency and safety of adalimumab treatment in patients with active rheumatoid arthritis unresponsive to standard therapy: Russian national study results |
|
| 卷 85, 编号 8 (2013) |
Editorial |
Pharmacotherapy for rheumatoid arthritis in the early 21st century: Russian and international experience |
|
| 卷 85, 编号 5 (2013) |
Editorial |
Diagnosis and problems in therapy of interstitial lung disease associated with rheumatoid arthritis |
|
| 卷 87, 编号 5 (2015) |
Editorial |
Left and right ventricular diastolic dysfunction in patients with early rheumatoid arthritis before prescribing disease-modifying antirheumatic therapy |
|
| 卷 88, 编号 5 (2016) |
Editorial |
Relationship between matrix metalloproteinase-3 levels and articular destructive changes in early and extended rheumatoid arthritis |
(Rus)
|
| 卷 88, 编号 5 (2016) |
Editorial |
N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs |
(Rus)
|
